Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03761498 · ClinicalTrials.gov registry record
Is There a Microbiome Associated With Poor Growth in Preterm Infants?
A clinical trial of Prematurity and Growth Failure, sponsored by University of Texas Southwestern Medical Center.
- Active
- Registry status
- 118
- Enrollment target
- 1
- Study location
NCT03761498: Active study of Prematurity and Growth Failure, sponsored by University of Texas Southwestern Medical Center.
NCT03761498 is a study of Prematurity and Growth Failure that is active but no longer recruiting, run by University of Texas Southwestern Medical Center. The registered enrollment target is 118 participants, below the 206-participant average among 21 other Prematurity trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03761498, a study of Prematurity and Growth Failure, is active but no longer recruiting, sponsored by University of Texas Southwestern Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- 118 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the relationship between growth and stool microbiota in premature infants.
Primary Outcome
alpha diversity of bacterial groups in normal growth vs. poor growth
Conditions Studied
Interventions
- OTHER Caloric Requirement
Study Locations (1)
Texas
- Parkland Hopsital and Health System - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2019-07-15 |
| Est. Completion | 2025-12-30 |
What the registry record for NCT03761498 still lists
NCT03761498 is an observational study that tracks outcomes without assigning an intervention. The registered 118 participants enrollment target is mid-sized for trials with a published cap, below the 206-participant average among 21 other Prematurity trials with a reported enrollment target (43% lower).
The record links to 3 conditions, with Prematurity appearing as the primary indexed condition, and to 1 intervention - of which Caloric Requirement is the first listed.
NCT03761498 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03761498 about?
NCT03761498 is a clinical study titled "Is There a Microbiome Associated With Poor Growth in Preterm Infants?". This study evaluates the relationship between growth and stool microbiota in premature infants.
What is the current status of trial NCT03761498?
This trial is currently active not recruiting. The enrollment target is 118 participants. The study started on 2019-07-15. Estimated completion is 2025-12-30.
What conditions does trial NCT03761498 study?
This clinical trial studies the following conditions: Prematurity, Growth Failure, Growth Disorders.
What interventions are being tested in trial NCT03761498?
The interventions under investigation include: Caloric Requirement (OTHER).
Who is sponsoring clinical trial NCT03761498?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03761498 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prematurity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03761498's enrollment target sits among peer trials
118 10th of 21 higher than 11 of 21 other Prematurity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prematurity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants
RECRUITING · Phase 2
-
The Impact of Music Medicine on Preterm Brain Development and Behavior
RECRUITING · NA
-
The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants
RECRUITING · NA
-
Nourishing Tomorrow: Role of Medically Tailored Groceries in Addressing Food Insecurity During Pregnancy
RECRUITING · NA
-
Evaluating Wearable Smart Sensors for Continuous Measurement of Vital Signs in ICU Patients
RECRUITING
-
Maternal Stress, Milk Composition, and Preterm Neurodevelopment
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03821623 · 118 participants · Phase 2
Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
- NCT04040959 · 118 participants · Phase 2
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
- NCT04696029 · 118 participants · Phase 2
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- NCT05254327 · 118 participants · Phase 2
Trial of the Efficacy and Safety of Short and Long Course Radiation Therapy With/Without BMX-001
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI